Van Well Daan 4

4 · SOPHiA GENETICS SA · Filed Apr 21, 2026

AI-generated summary of this filing

Updated Apr 21, 2026

SOPHiA GENETICS (SOPH) Chief Legal Officer Daan Van Well Sells 684 Shares

What Happened

Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 684 shares on April 20, 2026.
The reported weighted-average price was $5.20 per share (range $5.10–$5.29), for total proceeds of approximately $3,554. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.

Key Details

Transaction date: 2026-04-20; Filing date (Form 4): 2026-04-21 (timely).
Transaction type/code: Sale (S).
Shares sold: 684; Weighted-average price: $5.20; Price range: $5.10–$5.29.
Reported reason: Shares sold in the open market to satisfy tax withholding on RSUs that vested April 18, 2026 (Footnote F1).
Trading plan: Sales were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary (Footnote F1).
Additional note: The filer reports a weighted-average price and offers to provide per-price breakdown on request (Footnote F2).
Shares owned after the transaction: Not stated in this filing.

Context

These sales were routine tax-withholding dispositions of vested RSUs under a 10b5-1 plan, which typically do not signal discretionary insider selling. The dollar amount is modest (~$3.6k) relative to company-market activity.

Form 4

Period: 2026-04-20

Chief Legal Officer

Transactions

Footnotes (2)

[F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Elimara Brunetto as Attorney-in-Fact for Daan van Well|2026-04-21

1 file